Imperial College London

ProfessorPhilipMolyneaux

Faculty of MedicineNational Heart & Lung Institute

Professor of Interstitial Lung Disease
 
 
 
//

Contact

 

p.molyneaux

 
 
//

Location

 

Sir Alexander Fleming BuildingSouth Kensington Campus

//

Summary

 

Summary

Phil is the GSK/Asthma Lung UK Chair of Respiratory Research and Consultant in Interstitial lung disease at the Royal Brompton Hospital, where he is the director of the NIHR Clinical Research Facility.

Phil qualified from Guy's, King's and St Thomas' School of Medicine in 2004, where he completed an intercalated BSc. in Molecular Genetics. He undertook his SHO training at Guy’s and St Thomas’ and upon completion of the MRCP attained an NIHR Academic Clinical Fellow position in Respiratory medicine at Imperial College. He spent the next two years training at St Mary’s Hospital and working with Professors Cookson, Moffatt and Johnston studying the respiratory microbiome in COPD. 

An Asmarley training fellowship allowed him to undertake a PhD examining the host response to the respiratory microbiome in Idiopathic Pulmonary Fibrosis as part of the Prospective Study of Fibrosis In the Lung Endpoints (PROFILE) study with Professor Maher.

Having completed his clinical training in Respiratory and Critical Care Medicine he returned to Imperial joining the Fibrosis Research Group as a Senior Clinical Lecturer. He was awarded the Action for Pulmonary Fibrosis Mike Bray Fellowship which enabled him to establish his research group studying the interaction between the respiratory tract microbiota and innate immunity in pulmonary fibrosis.

Publications

Journals

Wu Z, Smith DJF, Yazbeck L, et al., 2024, Cough Severity Visual Analogue Scale Assesses Cough Burden and Predicts Survival in Idiopathic Pulmonary Fibrosis., Am J Respir Crit Care Med

Darawshy F, Molyneaux PL, Segal LN, 2024, Looking Beyond the Lower Airways for Microbes Affecting Pulmonary Fibrosis., Am J Respir Crit Care Med

Wu Z, Spencer LG, Banya W, et al., 2024, Morphine for treatment of cough in idiopathic pulmonary fibrosis (PACIFY COUGH): a prospective, multicentre, randomised, double-blind, placebo-controlled, two-way crossover trial, The Lancet Respiratory Medicine, ISSN:2213-2600

Lord JM, Veenith T, Sullivan J, et al., 2024, Accelarated immune ageing is associated with COVID-19 disease severity, Immunity and Ageing, Vol:21, ISSN:1742-4933

Davies HJ, Hammour G, Xiao H, et al., 2024, Physically Meaningful Surrogate Data for COPD, Ieee Open Journal of Engineering in Medicine and Biology

More Publications